Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Limited Cell Fluorescence Activated Cell-sort Sequencing (LC-FACSeq) is a method for detecting rare clones in leukemia

ABSTRACT: Limited Cell Fluorescence Activated Cell-sort Sequencing (LC-FACSeq) is a method for detecting rare clones in leukemia

PROVIDER: PRJNA629044 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR11637700.fastq.gz	Fastqsanger.gz
	SRR11637701.fastq.gz	Fastqsanger.gz
	SRR11637702.fastq.gz	Fastqsanger.gz
	SRR11637703.fastq.gz	Fastqsanger.gz
	SRR11637704.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 121

Similar Datasets

Limited Cell Fluorescence Activated Cell-sort Sequencing (LC-FACSeq) is a method for detecting rare clones in leukemia

Project description:Detecting and monitoring tumor clonal evolution in the setting of measurable residual disease is technically difficult due to 1) high sequencing background due to limited numbers of disease cells, 2) loss of tumor genetic material due to the need for high quality purified DNA, and 3) resource and bioinformatics intensive requirements of traditional next generation sequencing techniques. Limited Cell Fluorescence Activated Cell-sort Sequencing (LC-FACSeq), is a fast, reproducible, and cost effective amplicon based sequencing technique that does not require genomic material isolation. It can be used in the context of just a few hundred tumor cells and is easily generalization for monitoring clonal evolution in various different malignancies.

2020-08-10 | GSE149545 | GEO

Chromatium okenii LC strain:LC

Project description:Chromatium okenii LC strain:LC Genome sequencing

| PRJNA230878 | ENA

Juvenile Fluorescence

Project description:Juvenile Fluorescence Raw sequence reads

| PRJNA436185 | ENA

LC-FACSeq is a method for detecting rare clones in leukemia.

Project description:Detecting, characterizing, and monitoring rare populations of cells can increase testing sensitivity, give insight into disease mechanism, and inform clinical decision making. One area that can benefit from increased resolution is management of cancers in clinical remission but with measurable residual disease (MRD) by multicolor FACS. Detecting and monitoring genomic clonal resistance to treatment in the setting of MRD is technically difficult and resource intensive due to the limited amounts of disease cells. Here, we describe limited-cell FACS sequencing (LC-FACSeq), a reproducible, highly sensitive method of characterizing clonal evolution in rare cells relevant to different types of acute and chronic leukemias. We demonstrate the utility of LC-FACSeq for broad multigene gene panels and its application for monitoring sequential acquisition of mutations conferring therapy resistance and clonal evolution in long-term ibrutinib treatment of patients with chronic lymphocytic leukemia. This technique is generalizable for monitoring of other blood and marrow infiltrating cancers.

| S-EPMC7406301 | biostudies-literature

SORT-seq of Synovial Tissue Dentritic Cells from Rheumatoid arthritis

Project description:SORT-seq is a plate-based method of single-cell RNA sequencing (Muraro et al. 2016) is a partially robotized version of the CEL-seq2 protocol (Hashimshony et al. 2016). Synovial membranes from Rheumatoid arthritis' patients yield a relatively robust number of DCs using scRNAseq, we sought to validate this initial finding at protein level. We employed a rigorous gating strategy to sort specific ST DC subsets, developed based on CITEseq analysis, which was then confirmed by index cell plate sort sequencing (SORT-seq).

2024-12-09 | E-MTAB-14198 | biostudies-arrayexpress

Lactobacillus phage Lc-Nu

Project description:Lactobacillus phage Lc-Nu overview

| PRJNA69581 | ENA

Sequencing of ponatinib-resistant LC-2/ad derivatives (PR1 and PR2) and parental LC-2/ad cells

Project description:Sequencing of ponatinib-resistant LC-2/ad derivatives (PR1 and PR2) and parental LC-2/ad cells was performed in order to determine mechanisms of acquired resistance in the PR1 and PR2 cell lines. NRAS p.Q61K mutation identified in PR1 cells. Upregulation of wild-type EGFR signaling identified in PR2 cells.

2017-04-21 | GSE98030 | GEO

Vibrio parahaemolyticus strain:LC

Project description:Vibrio parahaemolyticus strain:LC Genome sequencing

| PRJNA940044 | ENA

Chlamydia trachomatis D-LC

Project description:Chlamydia trachomatis D-LC genome sequencing

| PRJNA48089 | ENA

Mycoplasmoides gallisepticum strain:LC

Project description:Mycoplasmoides gallisepticum strain:LC Genome sequencing

| PRJNA1200668 | ENA